Regulating drug for psychological stress symptoms

A psychological stress, drug technology, applied in the direction of drug combination, pharmaceutical formula, organic active ingredients, etc., can solve problems such as poor stability of drug efficacy, low efficacy rate, etc., achieve significant drug effect, enhance confidence and willingness, psychological and emotional state changes significantly

Inactive Publication Date: 2018-10-19
张涛
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0006] Another object of the present invention is to propose a psychological stress symptom regulating drug, which can overcome the problems of low effective rate and poor drug efficacy stability of existing psychological symptom regulating drugs, so as to be suitable for the treatment of patients with psychological stress at different stages need

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Embodiment 1, composition of a medicine for regulating psychological stress symptoms.

[0025] A medicine for regulating psychological stress symptoms, the components of which include ibuprofen and vitamin B6.

[0026] The ibuprofen is a non-steroidal nervous system anti-inflammatory drug, which inhibits the action potential of the cranial nerve and selectively reduces nerve impulses; the vitamin B6 is a drug for regulating neurotransmitter and cell membrane metabolism; the oryzanol is a drug for autonomic regulation .

[0027] The content ratio of each component in the psychological symptom regulating medicine, the highest value of ibuprofen content is 300 mg, the lowest value is 200 mg, and the middle value is 250 mg.

[0028] The highest value of the vitamin B6 is 30 mg, the lowest value is 20 mg, and the middle value is 25 mg.

[0029] The highest value of oryzanol is 30 mg, the lowest value is 20 mg, and the middle value is 25 mg.

Embodiment 2

[0030] Example 2, the pharmacological action design of each component in a medicine for regulating psychological stress symptoms.

[0031] The ibuprofen is a medicinal product, which inhibits the formation of cerebral cortex nerve cell impulses after entering the human body, maintains the stability of nerve cell membranes, repairs the function of damaged nerve cells, balances the substance metabolism basis of nerve cell membranes, and inhibits the psychological stress recovery period. The "flashback" effect caused by the shocking event induces the value conditional return to rationality and the selective expression of the forgetting effect in the psychological function.

[0032] The vitamin B6 is a medicinal product. After entering the human body, it can regulate the metabolic level of neurotransmitters and cell membranes, affect the metabolism of the neurotransmitter 5-hydroxytryptamine or its important metabolite 5-hydroxyindoleacetic acid (5-HIAA), and restore the state of p...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to the technical field of psychological counseling and treatment, and in particular, relates to a regulating drug for psychological stress symptoms. The regulating drug comprisesthe drug components comprising ibuprofen, vitamin B6 and oryzanol; the ibuprofen is a non-steroidal nervous system anti-inflammatory drug, inhibits the formation of a brain nerve action potential ina psychological stress state, inhibits a flashback effect in a psychological stress recovery period, and improves the selective expression intensity of a forgetting effect; the vitamin B5 is a neurotransmitter and cell membrane metabolism regulating drug, and repairs a neurotransmitter metabolic disorder state in the psychological stress state; the oryzanol is a plant nerve regulating drug, and improves the symptoms of autonomic nerve functional disorder. The compound drug has the regulating effect only on the nervous system metabolism and the plant nerve functions in the psychological stressstate. The drug compound preparation is taken once a day, and the application time is limited to half an hour before bed; the regulating drug makes the regulation and treatment difficulty of psychological stress symptoms significantly reduced, and is convenient for general psychologists to use.

Description

technical field [0001] The invention relates to the field of counseling and treatment of psychological stress, in particular to a medicine for regulating psychological stress symptoms. Background technique [0002] Counseling and treatment of psychological stress is an important medical operation for psychologists to evaluate and treat patients with psychological stress. Regulatory drugs for psychological stress symptoms are an important part of psychological stress counseling and treatment research in peacetime and wartime (disaster). The efficacy and convenience of psychological stress symptom regulating drugs have an important impact on expanding the application scope of psychological stress crisis intervention, so psychological stress symptom regulating drugs play a key role in psychological crisis intervention. [0003] In extreme environments such as emergency rescue and disaster relief and battlefields, psychological stress symptom regulating drugs can complete the p...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K31/575A61P25/00A61K31/4415A61K31/192
CPCA61K31/192A61K31/4415A61K31/575A61P25/00A61K2300/00
Inventor 张涛鱼敏段崇芳
Owner 张涛
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products